Cong Xue
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
- Oncology 22
- HER2/EGFR in Cancer Research 8
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 4
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Yuan-yuan Zhao (25 shared papers)Yan Huang (19 shared papers)Wenfeng Fang (16 shared papers)Roujun Peng (5 shared papers)Hongyun Zhao (11 shared papers)Shusen Wang (9 shared papers)Zhihuang Hu (12 shared papers)Tao Qin (9 shared papers)
- Journals
- 癌症：英文版 (7 papers)Oncotarget (6 papers)Drug Design Development and Therapy (4 papers)BMC Cancer (3 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Cong Xue
65 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 75
- Oncology 952
- Otorhinolaryngology 223
- Cancer Research 391
- Pulmonary and Respiratory Medicine 508
- Immunology 159
Countries citing papers authored by Cong Xue
This map shows the geographic impact of Cong Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Xue more than expected).
Fields of papers citing papers by Cong Xue
This network shows the impact of papers produced by Cong Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Xue. The network helps show where Cong Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 359 | |
| 2 | 2014 | 174 | |
| 3 | 2020 | 162 | |
| 4 | 2015 | 157 | |
| 5 | 2014 | 117 | |
| 6 | 2015 | 117 | |
| 7 | 2014 | 107 | |
| 8 | 2012 | 100 | |
| 9 | 2018 | 88 | |
| 10 | 2015 | 68 | |
| 11 | 2012 | 53 | |
| 12 | 2012 | 45 | |
| 13 | 2010 | 44 | |
| 14 | 2011 | 44 | |
| 15 | 2014 | 44 | |
| 16 | 2012 | 42 | |
| 17 | 2023 | 35 | |
| 18 | 2024 | 35 | |
| 19 | 2013 | 34 | |
| 20 | 2016 | 30 |
About Cong Xue
Cong Xue is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Surgery, having authored 66 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (8 papers), Head and Neck Cancer Studies (7 papers), Bladder and Urothelial Cancer Treatments (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Oncology (952 citations), Otorhinolaryngology (223 citations), Cancer Research (391 citations), Pulmonary and Respiratory Medicine (508 citations) and Immunology (159 citations). Cong Xue has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Yuan-yuan Zhao, Yan Huang, Wenfeng Fang, Roujun Peng, Hongyun Zhao, Shusen Wang, Zhihuang Hu, Tao Qin, Yuxiang Ma and Yunpeng Yang. Their work appears in journals such as 癌症：英文版, Oncotarget, Drug Design Development and Therapy, BMC Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.